ID   STAB2_RAT               Reviewed;        1431 AA.
AC   Q8CFM6;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   02-OCT-2024, entry version 115.
DE   RecName: Full=Stabilin-2;
DE   AltName: Full=Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2;
DE            Short=FEEL-2;
DE   AltName: Full=Hyaluronan receptor for endocytosis;
DE   Contains:
DE     RecName: Full=175 kDa stabilin-2;
DE     AltName: Full=175 kDa hyaluronan receptor for endocytosis;
DE   Flags: Precursor; Fragment;
GN   Name=Stab2 {ECO:0000250|UniProtKB:Q8WWQ8};
GN   Synonyms=Feel2, Hare {ECO:0000303|PubMed:12181351};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAG13634.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 1-18; 62-73; 103-120;
RP   122-136; 488-509; 604-619; 651-668; 1070-1075 AND 1120-1129, AND FUNCTION.
RC   STRAIN=Sprague-Dawley {ECO:0000312|EMBL:AAG13634.1};
RC   TISSUE=Endothelial cell;
RX   PubMed=12181351; DOI=10.1091/mbc.02-03-0048;
RA   Zhou B., Weigel J.A., Saxena A., Weigel P.H.;
RT   "Molecular cloning and functional expression of the rat 175-kDa hyaluronan
RT   receptor for endocytosis.";
RL   Mol. Biol. Cell 13:2853-2868(2002).
RN   [2]
RP   FUNCTION.
RX   PubMed=9061360; DOI=10.1093/glycob/7.1.15;
RA   Yannariello-Brown J., Zhou B., Weigel P.H.;
RT   "Identification of a 175 kDa protein as the ligand-binding subunit of the
RT   rat liver sinusoidal endothelial cell hyaluronan receptor.";
RL   Glycobiology 7:15-21(1997).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15572036; DOI=10.1016/j.yexcr.2004.09.017;
RA   Hansen B., Longati P., Elvevold K., Nedredal G.-I., Schledzewski K.,
RA   Olsen R., Falkowski M., Kzhyshkowska J., Carlsson F., Johansson S.,
RA   Smedsroed B., Goerdt S., Johansson S., McCourt P.;
RT   "Stabilin-1 and stabilin-2 are both directed into the early endocytic
RT   pathway in hepatic sinusoidal endothelium via interactions with
RT   clathrin/AP-2, independent of ligand binding.";
RL   Exp. Cell Res. 303:160-173(2005).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=17450384; DOI=10.1007/s00441-007-0387-5;
RA   Yoshida M., Nishikawa Y., Omori Y., Yoshioka T., Tokairin T., McCourt P.,
RA   Enomoto K.;
RT   "Involvement of signaling of VEGF and TGF-beta in differentiation of
RT   sinusoidal endothelial cells during culture of fetal rat liver cells.";
RL   Cell Tissue Res. 329:273-282(2007).
RN   [5]
RP   FUNCTION.
RX   PubMed=19359419; DOI=10.1152/ajpgi.90717.2008;
RA   Harris E.N., Baggenstoss B.A., Weigel P.H.;
RT   "Rat and human HARE/stabilin-2 are clearance receptors for high- and low-
RT   molecular-weight heparins.";
RL   Am. J. Physiol. 296:G1191-G1199(2009).
CC   -!- FUNCTION: Phosphatidylserine receptor that enhances the engulfment of
CC       apoptotic cells. Hyaluronan receptor that binds to and mediates
CC       endocytosis of hyaluronic acid (HA). Acts also, in different species,
CC       as a primary systemic scavenger receptor for heparin (Hep), chondroitin
CC       sulfate (CS), dermatan sulfate (DS), nonglycosaminoglycan (GAG),
CC       acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides
CC       and advanced glycation end products (AGE). May serve to maintain tissue
CC       integrity by supporting extracellular matrix turnover or it may
CC       contribute to maintaining fluidity of bodily liquids by resorption of
CC       hyaluronan. Counter receptor which plays an important role in
CC       lymphocyte recruitment in the hepatic vasculature. Binds to both Gram-
CC       positive and Gram-negative bacteria and may play a role in defense
CC       against bacterial infection. The proteolytically processed 175 kDa form
CC       also functions as an endocytosis receptor for heparin internalization
CC       as well as HA and CS. {ECO:0000269|PubMed:12181351,
CC       ECO:0000269|PubMed:15572036, ECO:0000269|PubMed:19359419,
CC       ECO:0000269|PubMed:9061360}.
CC   -!- SUBUNIT: Interacts with GULP1, heparin, alpha-M/beta-2 integrin (ITGAM
CC       and ITGB2), and thymosin beta 4 (TMSB4X). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8WWQ8}. Cell
CC       membrane {ECO:0000269|PubMed:15572036}; Single-pass type I membrane
CC       protein {ECO:0000269|PubMed:15572036}.
CC   -!- TISSUE SPECIFICITY: Initially expressed in all vascular cells,
CC       including those of sinusoidal-like structures, vitellin veins, and
CC       hepatic veins or sinus venosus, in E13.5 fetal liver. The expression
CC       then progressively disappears in the portal and hepatic veins, but the
CC       expression in sinusoidals endothelial cells (SECs) is retained and
CC       becomes stronger during development. {ECO:0000269|PubMed:17450384}.
CC   -!- DOMAIN: Recognizes phosphatidyl serine via its epidermal growth factor-
CC       like domains.
CC   -!- PTM: Glycosylated.
CC   -!- PTM: Proteolytically processed to yield a 175 kDa protein.
CC       {ECO:0000269|PubMed:12181351}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY007370; AAG13634.1; -; mRNA.
DR   AlphaFoldDB; Q8CFM6; -.
DR   SMR; Q8CFM6; -.
DR   STRING; 10116.ENSRNOP00000056294; -.
DR   GlyCosmos; Q8CFM6; 15 sites, No reported glycans.
DR   GlyGen; Q8CFM6; 15 sites.
DR   PhosphoSitePlus; Q8CFM6; -.
DR   UCSC; RGD:628822; rat.
DR   AGR; RGD:628822; -.
DR   RGD; 628822; Stab2.
DR   eggNOG; KOG1218; Eukaryota.
DR   InParanoid; Q8CFM6; -.
DR   PhylomeDB; Q8CFM6; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0038024; F:cargo receptor activity; ISO:RGD.
DR   GO; GO:0005540; F:hyaluronic acid binding; IDA:UniProtKB.
DR   GO; GO:0030169; F:low-density lipoprotein particle binding; ISO:RGD.
DR   GO; GO:0005041; F:low-density lipoprotein particle receptor activity; ISO:RGD.
DR   GO; GO:0005044; F:scavenger receptor activity; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0042742; P:defense response to bacterium; ISO:RGD.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IDA:UniProtKB.
DR   GO; GO:0030214; P:hyaluronan catabolic process; ISO:RGD.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISO:RGD.
DR   GO; GO:0016192; P:vesicle-mediated transport; ISO:RGD.
DR   Gene3D; 2.30.180.10; FAS1 domain; 4.
DR   Gene3D; 2.10.25.10; Laminin; 7.
DR   Gene3D; 3.10.100.10; Mannose-Binding Protein A, subunit A; 1.
DR   Gene3D; 2.170.300.10; Tie2 ligand-binding domain superfamily; 1.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR024731; EGF_dom.
DR   InterPro; IPR036378; FAS1_dom_sf.
DR   InterPro; IPR000782; FAS1_domain.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR002049; LE_dom.
DR   InterPro; IPR000538; Link_dom.
DR   InterPro; IPR051146; PS_Receptors/PDI.
DR   PANTHER; PTHR24038; STABILIN; 1.
DR   PANTHER; PTHR24038:SF0; STABILIN-2; 1.
DR   Pfam; PF12947; EGF_3; 5.
DR   Pfam; PF02469; Fasciclin; 3.
DR   Pfam; PF00193; Xlink; 1.
DR   SMART; SM00181; EGF; 11.
DR   SMART; SM00179; EGF_CA; 2.
DR   SMART; SM00554; FAS1; 4.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; C-type lectin-like; 1.
DR   SUPFAM; SSF57196; EGF/Laminin; 3.
DR   SUPFAM; SSF82153; FAS1 domain; 4.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   PROSITE; PS00022; EGF_1; 3.
DR   PROSITE; PS01186; EGF_2; 8.
DR   PROSITE; PS50026; EGF_3; 10.
DR   PROSITE; PS01248; EGF_LAM_1; 2.
DR   PROSITE; PS50213; FAS1; 4.
DR   PROSITE; PS01241; LINK_1; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cytoplasm; Direct protein sequencing; Disulfide bond;
KW   EGF-like domain; Endocytosis; Glycoprotein; Hyaluronic acid;
KW   Laminin EGF-like domain; Membrane; Receptor; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           <1..1431
FT                   /note="Stabilin-2"
FT                   /id="PRO_0000007716"
FT   CHAIN           1..1431
FT                   /note="175 kDa stabilin-2"
FT                   /id="PRO_0000007717"
FT   TOPO_DOM        <1..1322
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1323..1343
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1344..1431
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          2..130
FT                   /note="FAS1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00082"
FT   DOMAIN          207..272
FT                   /note="Laminin EGF-like 1"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          296..334
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          335..376
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          377..418
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          419..460
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          460..588
FT                   /note="FAS1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00082"
FT   DOMAIN          604..745
FT                   /note="FAS1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00082"
FT   DOMAIN          822..887
FT                   /note="Laminin EGF-like 2"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          947..987
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          988..1030
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1063..1156
FT                   /note="Link"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT   DOMAIN          1176..1310
FT                   /note="FAS1 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00082"
FT   REGION          1368..1378
FT                   /note="Interaction with TMSB4X"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        112
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        231
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        243
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        301
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        329
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        437
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        607
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        858
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        929
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1145
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1161
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1233
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1249
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1258
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        212..226
FT                   /evidence="ECO:0000250"
FT   DISULFID        220..236
FT                   /evidence="ECO:0000250"
FT   DISULFID        238..247
FT                   /evidence="ECO:0000250"
FT   DISULFID        259..270
FT                   /evidence="ECO:0000250"
FT   DISULFID        263..280
FT                   /evidence="ECO:0000250"
FT   DISULFID        282..291
FT                   /evidence="ECO:0000250"
FT   DISULFID        300..310
FT                   /evidence="ECO:0000250"
FT   DISULFID        304..320
FT                   /evidence="ECO:0000250"
FT   DISULFID        322..333
FT                   /evidence="ECO:0000250"
FT   DISULFID        339..352
FT                   /evidence="ECO:0000250"
FT   DISULFID        346..362
FT                   /evidence="ECO:0000250"
FT   DISULFID        364..375
FT                   /evidence="ECO:0000250"
FT   DISULFID        381..394
FT                   /evidence="ECO:0000250"
FT   DISULFID        388..404
FT                   /evidence="ECO:0000250"
FT   DISULFID        406..417
FT                   /evidence="ECO:0000250"
FT   DISULFID        423..436
FT                   /evidence="ECO:0000250"
FT   DISULFID        430..446
FT                   /evidence="ECO:0000250"
FT   DISULFID        448..459
FT                   /evidence="ECO:0000250"
FT   DISULFID        827..841
FT                   /evidence="ECO:0000250"
FT   DISULFID        835..851
FT                   /evidence="ECO:0000250"
FT   DISULFID        853..862
FT                   /evidence="ECO:0000250"
FT   DISULFID        874..885
FT                   /evidence="ECO:0000250"
FT   DISULFID        879..895
FT                   /evidence="ECO:0000250"
FT   DISULFID        897..906
FT                   /evidence="ECO:0000250"
FT   DISULFID        951..964
FT                   /evidence="ECO:0000250"
FT   DISULFID        958..973
FT                   /evidence="ECO:0000250"
FT   DISULFID        975..986
FT                   /evidence="ECO:0000250"
FT   DISULFID        992..1006
FT                   /evidence="ECO:0000250"
FT   DISULFID        1000..1016
FT                   /evidence="ECO:0000250"
FT   DISULFID        1018..1029
FT                   /evidence="ECO:0000250"
FT   DISULFID        1085..1154
FT                   /evidence="ECO:0000250"
FT   DISULFID        1109..1130
FT                   /evidence="ECO:0000250"
FT   NON_TER         1
FT                   /evidence="ECO:0000312|EMBL:AAG13634.1"
SQ   SEQUENCE   1431 AA;  155914 MW;  3340A8F7AF366722 CRC64;
     SLPSLLTRLE QMPDYSIFRG YIIHYNLASA IESADAYTVF VPNNEAIENY IREKKATSLK
     EDILRYHVVL GEKLLKNDLH NGMHRETMLG FSYLLAFFLR NDQLYVNEAP INYTNVATDK
     GVIHGLEKVL EIQKNRCDNN DTIIVRGECG KCSQQAPCPL ETKPLRETRK CIYSIYFMGK
     RSVFIGCQPQ CVRTIITRAC CAGFFGPQCQ ACPGRGQNVC SGNGFCLDGV NGTGTCQCGL
     GFNGTACETC TEGKYGIHCD QACSCVHGRC SQGPLGDGSC DCDVGWRGVK CDMEITTDNC
     NGTCHTSANC LLDPDGKASC KCAAGFRGNG TVCTAINACE TSNGGCSTKA DCKRTTPGNR
     VCVCKAGYTG DGIVCLEINP CLENHGGCDR NAECTQTGPN QAVCNCLPKY TGDGKVCSLI
     NVCLTNNGGC SPFAFCNYTE QDQRICTCKP DYTGDGIVCR GSIYGELPKN PSTSQYFFQL
     QEHAVRELAG PGPFTVFAPL SSSFNHEPRI KDWDQQGLMS QVLRYHVVGC QQLLLDNLKV
     TTSATTLQGE PVSISVSQDT VFINNEAKVL SSDIISTNGV IHVIDKLLSP KNLLITPKDA
     LGRVLQNLTT VAANHGYTKF SKLIQDSGLL SVITDSIHTP VTVFWPTDKA LEALPPEQQD
     FLFNQDNKDK LKSYLKFHVI RDSKALASDL PRSASWKTLQ GSELSVRCGT GSDIGELFLN
     EQMCRFIHRG LLFDVGVAYG IDCLLMNPTL GGRCDTFTTF DIPGECGSCI FTPKCPLKSK
     PKGVKKKCIY NPLPFRRNVE GCQNLCTVVI QTPRCCHGYF MPDCQACPGG PDTPCNNRGM
     CRDLYTPMGQ CLCHTGFNGT ACELCWHGRF GPDCQPRSCS EHGQCDEGIT GSGECLCETG
     WTAASCDTPT AVFAVCTPAC SVHATCTENN TCVCNLNYEG DGITCTVVDF CKQNNGGCAK
     VAKCSQKGTQ VSCSCKKGYK GDGYSCIEID PCADGVNGGC HEHATCRMTG PGKHKCECKS
     HYVGDGVDCE PEQLPLDRCL QDNGQCHPDA SCADLYFQDT TVGVFHLRSP LGQYKLTFDK
     AKEACAKEAA TIATYNQLSY AQKAKYHLCS AGWLESGRVA YPTTYASQKC GANVVGIVDY
     GSRANKSEMW DVFCYRMKDV NCTCKAGYVG DGFSCSGNLL QVLMSFPSLT NFLTEVLAFS
     KSSARGQAFL KHLTDLSIRG TLFVPQNSGL PGNKSLSGRD IEHHLTNVNV SFYNDLVNGT
     FLRTMLGSQL LITFSQDQLH QETRFVDGRS ILQWDIIAAN GILHIISEPL RAPPTAATAA
     HSGLGTGIFC AVVLVTGAIA LAAYSYFRLK QRTTGFQRFD QKRTLMSWLL ASSSPRISQT
     LCMRPQRRHP QSPPVTPSQT LENRIWRTAT LWGHCGPDMR SQQATTVTVP R
//
